These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1314334

  • 1. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S, Hohlfeld R.
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Feb; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 Feb; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 5. Current medical treatment of multiple sclerosis.
    Alter M.
    Clin Ther; 1983 Feb; 5(5):455-60. PubMed ID: 6193881
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B, Pirskanen R.
    Br Med J (Clin Res Ed); 1985 Sep 28; 291(6499):850-1. PubMed ID: 2996688
    [Abstract] [Full Text] [Related]

  • 11. [Current therapy of multiple sclerosis].
    Vass K, Schmied M.
    Wien Med Wochenschr; 1996 Sep 28; 146(19-20):514-9. PubMed ID: 9082651
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
    Jyoichi T, Kamegai M, Noda Y, Shimojo S, Miyahara T.
    Rinsho Shinkeigaku; 1986 Sep 28; 26(9):907-9. PubMed ID: 3791770
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985 Sep 28; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 18. [Multiple sclerosis: an update].
    Duquette P.
    Union Med Can; 1988 Aug 28; 118(3):231-5. PubMed ID: 3051618
    [No Abstract] [Full Text] [Related]

  • 19. [Plasmapheresis in multiple sclerosis].
    Fuchs S, Pogglitsch H, Ladurner G, Lechner H.
    Wien Klin Wochenschr; 1984 Jan 20; 96(2):67-9. PubMed ID: 6710999
    [Abstract] [Full Text] [Related]

  • 20. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
    Trouillas P, Neuschwander P, Nighoghossian N, Adeleine P, Tremisi P.
    Rev Neurol (Paris); 1989 Jan 20; 145(5):369-77. PubMed ID: 2662340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.